Skip to main content
OpenTrials

Clinical trial condition

Ciliopathies

Explore clinical trials studying Ciliopathies. Study availability and eligibility vary by location and protocol.

291 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Ciliopathies trial results

Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

NCT07228364

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Loma Linda, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Orlando, Florida, United States
View all 15 locations
View Trial Details
Recruiting

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

NCT07280585

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +11 more
Locations
  • Vorarlberger Krankenhaus-Betriebsgesellschaft Feldkirch, Austria
  • Medizinische Universitaet Innsbruck Innsbruck, Austria
  • Robert Bosch Gesellschaft für Medizinische Forschung mbH Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum Nürnberg Nuremberg, Bavaria, Germany
View all 30 locations
View Trial Details
Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

NCT06714006

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street, Southport, Gold Coast, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive Liverpool, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
View Trial Details
Recruiting

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

NCT07405164

Conditions
Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +11 more
Locations
  • Beth Israel Deaconess Medical Center ( Site 0107) Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute ( Site 0105) Boston, Massachusetts, United States
  • Karmanos Cancer Center ( Site 0108) Detroit, Michigan, United States
  • Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100) Philadelphia, Pennsylvania, United States
View all 49 locations
View Trial Details
Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions
Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations
  • Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States
  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States
  • Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States
  • University of Iowa ( Site 0104) Iowa City, Iowa, United States
View all 84 locations
View Trial Details
Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

NCT04782258

Conditions
Abnormalities, Multiple, Autosomal Recessive Polycystic Kidney (ARPKD), Ciliopathies, +14 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology Chicago, Illinois, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View all 23 locations
View Trial Details

Related conditions